124 related articles for article (PubMed ID: 20565336)
21. Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity.
Fulp A; Bortoff K; Zhang Y; Seltzman H; Snyder R; Maitra R
Bioorg Med Chem Lett; 2011 Oct; 21(19):5711-4. PubMed ID: 21875798
[TBL] [Abstract][Full Text] [Related]
22. Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity.
Zádor F; Kocsis D; Borsodi A; Benyhe S
Neurochem Int; 2014 Feb; 67():14-22. PubMed ID: 24508403
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.
Lange JH; Kruse CG
Chem Rec; 2008; 8(3):156-68. PubMed ID: 18563799
[TBL] [Abstract][Full Text] [Related]
24. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.
Chen W; Tang H; Liu H; Long L; Gong Z; Zheng J; Chi M; Xie Y; Zheng Z; Li S; Wang L
Eur J Pharmacol; 2010 Jul; 637(1-3):178-85. PubMed ID: 20380831
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA
Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087
[TBL] [Abstract][Full Text] [Related]
26. Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands.
Murineddu G; Asproni B; Corona P; Piras S; Lazzari P; Ruiu S; Legnani L; Toma L; Pinna GA
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035548
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity.
Fulp A; Bortoff K; Seltzman H; Zhang Y; Mathews J; Snyder R; Fennell T; Maitra R
J Med Chem; 2012 Mar; 55(6):2820-34. PubMed ID: 22372835
[TBL] [Abstract][Full Text] [Related]
28. Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.
Zhang Y; Burgess JP; Brackeen M; Gilliam A; Mascarella SW; Page K; Seltzman HH; Thomas BF
J Med Chem; 2008 Jun; 51(12):3526-39. PubMed ID: 18512901
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in CB1 cannabinoid receptor antagonists.
Lange JH; Kruse CG
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):498-506. PubMed ID: 15338959
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands.
Silvestri R; Ligresti A; La Regina G; Piscitelli F; Gatti V; Lavecchia A; Brizzi A; Pasquini S; Allarà M; Fantini N; Carai MA; Bigogno C; Rozio MG; Sinisi R; Novellino E; Colombo G; Di Marzo V; Dondio G; Corelli F
Eur J Med Chem; 2010 Dec; 45(12):5878-86. PubMed ID: 20943290
[TBL] [Abstract][Full Text] [Related]
31. Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists.
Aghazadeh Tabrizi M; Baraldi PG; Saponaro G; Moorman AR; Romagnoli R; Preti D; Baraldi S; Ruggiero E; Tintori C; Tuccinardi T; Vincenzi F; Borea PA; Varani K
J Med Chem; 2013 Jun; 56(11):4482-96. PubMed ID: 23697626
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
Lange JH; Coolen HK; van der Neut MA; Borst AJ; Stork B; Verveer PC; Kruse CG
J Med Chem; 2010 Feb; 53(3):1338-46. PubMed ID: 20047331
[TBL] [Abstract][Full Text] [Related]
33. Crystal Structure of the Human Cannabinoid Receptor CB
Hua T; Vemuri K; Pu M; Qu L; Han GW; Wu Y; Zhao S; Shui W; Li S; Korde A; Laprairie RB; Stahl EL; Ho JH; Zvonok N; Zhou H; Kufareva I; Wu B; Zhao Q; Hanson MA; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Cell; 2016 Oct; 167(3):750-762.e14. PubMed ID: 27768894
[TBL] [Abstract][Full Text] [Related]
34. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.
Kumar Srivastava B; Soni R; Patel JZ; Jha S; Shedage SA; Gandhi N; Sairam KV; Pawar V; Sadhwani N; Mitra P; Jain MR; Patel PR
Bioorg Med Chem Lett; 2008 Jul; 18(14):3882-6. PubMed ID: 18585913
[TBL] [Abstract][Full Text] [Related]
35. Scaffold hopping strategy toward original pyrazolines as selective CB₂ receptor ligands.
Gembus V; Furman C; Millet R; Mansouri R; Chavatte P; Levacher V; Brière JF
Eur J Med Chem; 2012 Dec; 58():396-404. PubMed ID: 23151320
[TBL] [Abstract][Full Text] [Related]
36. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
37. A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives.
Lazzari P; Distinto R; Manca I; Baillie G; Murineddu G; Pira M; Falzoi M; Sani M; Morales P; Ross R; Zanda M; Jagerovic N; Pinna GA
Eur J Med Chem; 2016 Oct; 121():194-208. PubMed ID: 27240274
[TBL] [Abstract][Full Text] [Related]
38. Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists.
Szabó G; Varga B; Páyer-Lengyel D; Szemzo A; Erdélyi P; Vukics K; Szikra J; Hegyi E; Vastag M; Kiss B; Laszy J; Gyertyán I; Fischer J
J Med Chem; 2009 Jul; 52(14):4329-37. PubMed ID: 19527048
[TBL] [Abstract][Full Text] [Related]
39. Structural-activity relationship study on C-4 carbon atom of the CB1 antagonist SR141716: synthesis and pharmacological evaluation of 1,2,4-triazole-3-carboxamides.
Jagerovic N; Hernandez-Folgado L; Alkorta I; Goya P; Martín MI; Dannert MT; Alsasua A; Frigola J; Cuberes MR; Dordal A; Holenz J
Eur J Med Chem; 2006 Jan; 41(1):114-20. PubMed ID: 16289480
[TBL] [Abstract][Full Text] [Related]
40. Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.
Tobiishi S; Sasada T; Nojiri Y; Yamamoto F; Mukai T; Ishiwata K; Maeda M
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1213-7. PubMed ID: 17666847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
